Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceuticals targeting cancer and inflammatory diseases. Its structure enables selective binding to enzyme active sites, making it valuable in drug discovery. Commonly employed in the development of tyrosine kinase inhibitors for oncology applications. Also utilized in research settings to design compounds with improved metabolic stability and target specificity.